Melissa Delamora
Nurse Practitioner · Reno, NVNPI 1003257775
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,625 of the $20,113 with a category attached, or 82.7%. AbbVie accounts for 87.1% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2023 at $8,306 and has fallen 72.9% since, to $2,248 in 2025. Among nurse practitioner clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 175 payments — averaging $114.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$18K
- Abbott$421
- Saluda Medical Americas, Inc.$325
- SPR Therapeutics, Inc$254
- Pfizer$208
- Vertos Medical, Inc.$168
- plus $1K from 25 others
Across 1 payment — averaging $39.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$40
What the payments were for
- Speaking & faculty fees$16,62583%
- Food & beverage$3,47517%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 66 | $17,521 |
| Abbott | 19 | $421 |
| Saluda Medical Americas, Inc. | 19 | $325 |
| SPR Therapeutics, Inc | 3 | $254 |
| Pfizer | 10 | $208 |
| Vertos Medical, Inc. | 2 | $168 |
| Nevro Corp. | 2 | $159 |
| Relievant Medsystems, Inc. | 8 | $123 |
| Amgen | 5 | $111 |
| Vertex | 4 | $109 |
| Collegium Pharmaceutical, Inc. | 5 | $93 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $64 |
| Nalu Medical, Inc. | 2 | $55 |
| AstraZeneca | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Forte Bio-pharma LLC | 1 | $47 |
| Novartis | 2 | $37 |
| Lundbeck LLC | 2 | $37 |
| GSK | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $28 |
| Lilly USA, LLC | 2 | $28 |
| GRT US Holding, Inc. | 1 | $25 |
| Almatica Pharma LLC | 1 | $23 |
| Boston Scientific | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Stimwave Technologies Incorporated | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$12,875
- UBRELVY$11,625
- SPRINT PNS System$235
- mild Device Kit$163
- Senza$139
How this compares
$20,113 in reported general payments places this provider in the 95th percentile of 933 nurse practitioner providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 421 | $10,660 |
| Pregabalin | 238 | $6,249 |
| OxycontinOxycodone Hcl | 17 | $6,019 |
| Gabapentin | 297 | $3,833 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 119 | $3,131 |
| Oxycodone Hcl | 155 | $2,613 |
| Lidocaine | 14 | $1,787 |
| Morphine Sulfate ErMorphine Sulfate | 66 | $1,206 |
| Fentanyl | 12 | $968 |
| Tizanidine Hcl | 92 | $847 |
| Cyclobenzaprine Hcl | 80 | $605 |
| Duloxetine Hcl | 59 | $542 |
| Tramadol Hcl | 67 | $489 |
| Ibuprofen | 42 | $385 |
| Methocarbamol | 39 | $343 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Reno
- Darian ThorpReno$18K
- Mary Beth MedinaReno$11K
- Kristen BowmanReno$10K
- Laura HayReno$8K
- Laura HarshReno$7K
- Mary HelmreichReno$7K
- Rhonda StrunkReno$7K
- Rachael HueftleReno$7K
- Rhonda NavarroReno$7K
- Julie SimeoniReno$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.